Mounjaro Approved for Blood Glucose Control in Type 2 Diabetes

FRIDAY, May 20, 2022 -- Mounjaro (tirzepatide) injection was approved as an addition to diet and exercise to improve blood glucose control in adults with type 2 diabetes, the U.S. Food and Drug Administration announced May 13. The first-in-class...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news